Amarillo VA pharmacy compounding for oncology medications

Active Awarded Last action

Contract number
36C25726N0093
Awardee
Awarding agency
Obligated
$225,000

Award facts

Contract value 100% obligated
$225,000.00 Current and potential, with all options
Completion date 99% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Amarillo, TX 79106, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 · Administrative modification to correct period of performance on the task order $0
Supplemental Agreement for work within scope P00001 · Amarillo VA pharmacy compounding for oncology medications--increase modification for $125K $125,000
Original award $100,000

About this award

This administrative modification corrects the period of performance for a delivery order issued under an indefinite delivery contract for pharmacy compounding services at the Amarillo VA Healthcare System. The award to Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, carries a ceiling value of $225,000 and utilizes a firm fixed-price structure. The delivery order supports the Department of Veterans Affairs' Veterans Integrated Service Network 17 (VISN 17) and involves specialized oncology medication compounding services. The contract was awarded without set-aside designations, indicating full and open competition. The ultimate completion date is October 31, 2026, with work performed in Amarillo, Texas.

Optum Infusion Services 308, LLC specializes in pharmaceutical compounding and infusion services, with particular expertise in aseptic chemotherapy compounding, hazardous drug preparation, and oncology medication formulation that complies with FDA 503A standards and USP requirements. The contractor currently holds seven active indefinite delivery contracts with the VA across multiple VISNs, collectively valued at approximately $16.6 million, demonstrating established capability in delivering critical pharmaceutical support services to VA cancer treatment programs. This administrative modification ensures proper documentation of the task order's performance period while maintaining continuity of specialized compounding services essential to the VA's oncology care operations.

Quick answers

Who was awarded contract 36C25726N0093?

36C25726N0093 was awarded to Optum Infusion Services 308, LLC by Veterans Integrated Service Network 17 (Veterans Health Administration) on November 1, 2025.

How much is contract 36C25726N0093 worth?

The government has obligated $225,000 on 36C25726N0093.

Is contract 36C25726N0093 an order under another contract?

Yes. 36C25726N0093 is a delivery order under 36C25726D0022, an indefinite delivery contract.

Was contract 36C25726N0093 competed?

The extent of competition for 36C25726N0093 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award